X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE MERCK LTD TTK HEALTHCARE/
MERCK LTD
 
P/E (TTM) x 33.1 35.0 94.7% View Chart
P/BV x 6.1 3.9 155.8% View Chart
Dividend Yield % 0.5 0.7 66.0%  

Financials

 TTK HEALTHCARE   MERCK LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
MERCK LTD
Dec-16
TTK HEALTHCARE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs6631,060 62.6%   
Low Rs399623 64.0%   
Sales per share (Unadj.) Rs535.6632.4 84.7%  
Earnings per share (Unadj.) Rs15.945.7 34.9%  
Cash flow per share (Unadj.) Rs20.062.3 32.1%  
Dividends per share (Unadj.) Rs4.0011.00 36.4%  
Dividend yield (eoy) %0.81.3 57.6%  
Book value per share (Unadj.) Rs137.6388.8 35.4%  
Shares outstanding (eoy) m7.7716.60 46.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 74.5%   
Avg P/E ratio x33.318.4 181.0%  
P/CF ratio (eoy) x26.513.5 196.4%  
Price / Book Value ratio x3.92.2 178.4%  
Dividend payout %25.124.1 104.3%   
Avg Mkt Cap Rs m4,12713,969 29.5%   
No. of employees `0001.71.6 107.9%   
Total wages/salary Rs m6071,487 40.8%   
Avg. sales/employee Rs Th2,436.76,631.9 36.7%   
Avg. wages/employee Rs Th355.2939.2 37.8%   
Avg. net profit/employee Rs Th72.5479.4 15.1%   
INCOME DATA
Net Sales Rs m4,16210,498 39.6%  
Other income Rs m61242 25.2%   
Total revenues Rs m4,22310,741 39.3%   
Gross profit Rs m1971,135 17.4%  
Depreciation Rs m32276 11.5%   
Interest Rs m300-   
Profit before tax Rs m1971,102 17.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73343 21.2%   
Profit after tax Rs m124759 16.3%  
Gross profit margin %4.710.8 43.8%  
Effective tax rate %37.031.1 118.8%   
Net profit margin %3.07.2 41.2%  
BALANCE SHEET DATA
Current assets Rs m1,6296,410 25.4%   
Current liabilities Rs m1,0588,828 12.0%   
Net working cap to sales %13.7-23.0 -59.5%  
Current ratio x1.50.7 212.1%  
Inventory Days Days3058 51.6%  
Debtors Days Days3438 87.5%  
Net fixed assets Rs m5561,406 39.6%   
Share capital Rs m78166 46.8%   
"Free" reserves Rs m8786,286 14.0%   
Net worth Rs m1,0696,455 16.6%   
Long term debt Rs m1590-   
Total assets Rs m2,3998,828 27.2%  
Interest coverage x7.6NM-  
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.2 145.9%   
Return on assets %6.48.6 74.6%  
Return on equity %11.611.8 98.5%  
Return on capital %18.517.1 108.1%  
Exports to sales %0.88.3 9.5%   
Imports to sales %1.421.0 6.7%   
Exports (fob) Rs m33869 3.8%   
Imports (cif) Rs m582,209 2.6%   
Fx inflow Rs m33959 3.4%   
Fx outflow Rs m632,612 2.4%   
Net fx Rs m-30-1,653 1.8%   
CASH FLOW
From Operations Rs m1271,070 11.8%  
From Investments Rs m-146-750 19.5%  
From Financial Activity Rs m22-150 -14.6%  
Net Cashflow Rs m3171 1.5%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.7 18.2 20.3%  
FIIs % 5.2 1.0 520.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 29.1 88.7%  
Shareholders   12,723 28,591 44.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  PFIZER  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 16, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS